“4. THE EFFICACY OF SECOND-LINE TREATMENT WITH DOCETAXEL FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER STAGE IIIB-IV AT E HOSPITAL”, YHCĐ, vol. 64, no. 1, Dec. 2022, doi: 10.52163/yhc.v64i1.567.